{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:25:39Z","timestamp":1777861539380,"version":"3.51.4"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aimed to describe the clinicopathological landscape of thyroid disease, summarize long-term management trends of thyroid carcinoma (TC) and lymph node metastasis (LNM) from 1999 to 2018, and develop a nomogram to predict central lymph node metastasis (CLNM) in patients with T1-stage papillary thyroid carcinoma (PTC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 34,420 patients with thyroid disease were included for landscape analysis, among whom 18,917 patients with TC were analyzed for management trends. Subsequently, 11,760 patients with T1-stage PTC were enrolled to identify risk factors for CLNM. A predictive nomogram was constructed using multivariable logistic regression and internally validated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among all patients, 22,919 were diagnosed with thyroid cancer and 11,501 with benign nodules. The proportion of TC increased steadily, reaching 99.3% in 2018. PTC accounted for 99.3% of TC cases, while the proportion of papillary thyroid microcarcinoma showed a slight decline. The rate of central lymph node dissection increased from 34.4% to 97%, whereas the CLNM rate decreased from 81.8% to 55%. In contrast, lateral lymph node dissection declined from 58.3% to 28.8%, with a corresponding reduction in lateral lymph node metastasis. Younger age, male sex, larger maximum tumor diameter (MTD), multifocality, lymphovascular invasion, and capsule invasion were identified as independent risk factors for CLNM (all p&amp;lt;0.05). The optimal MTD cutoff was 0.75\u00a0cm. The nomogram showed good discrimination (C-index 0.715) and satisfactory calibration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrates evolving patterns and increasing standardization in thyroid cancer management over two decades. The proposed nomogram may serve as a postoperative pathology-based risk stratification tool to support individualized management and follow-up in patients with T1-stage PTC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1776293","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:24:23Z","timestamp":1777523063000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological landscape and management trends of thyroid carcinoma over two decades: a single-institution study and risk stratification of central lymph node metastasis in T1 papillary thyroid carcinoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Li\u2019nan","family":"Qin","sequence":"first","affiliation":[{"name":"Department of Head and Neck Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xindi","family":"Ke","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongdu","family":"Nie","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jncc.2022.02.002","article-title":"Cancer incidence and mortality in China, 2016","volume":"2","author":"Zheng","year":"2022","journal-title":"J Natl Cancer Cent"},{"key":"B2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 american thyroid association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/000313480507100907","article-title":"The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer","volume":"71","author":"Podnos","year":"2005","journal-title":"Am Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2015142470","article-title":"Association of preoperative US features and recurrence in patients with classic papillary thyroid carcinoma","volume":"277","author":"Kim","year":"2015","journal-title":"Radiology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02230-7","article-title":"Time trend analysis of thyroid cancer surgery in China: single institutional database analysis of 15,000 patients","volume":"68","author":"Sui","year":"2020","journal-title":"Endocrine"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-012-1507-2","article-title":"Level VI lymph node dissection does not decrease radioiodine uptake in patients undergoing radioiodine ablation for differentiated thyroid cancer","volume":"36","author":"Yoo","year":"2012","journal-title":"World J Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2019-0532","article-title":"Role of prophylactic central compartment lymph node dissection on the outcome of patients with papillary thyroid carcinoma and synchronous ipsilateral cervical lymph node metastases","volume":"26","author":"De Napoli","year":"2020","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2012.08.053","article-title":"Prospective evaluation of total thyroidectomy versus ipsilateral versus bilateral central neck dissection in patients with clinically node-negative papillary thyroid carcinoma","volume":"152","author":"Raffaelli","year":"2012","journal-title":"Surgery"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.18526","article-title":"Prevalence of Hashimoto thyroiditis in adults with papillary thyroid cancer and its association with cancer recurrence and outcomes","volume":"4","author":"Xu","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ijsu.2017.12.029","article-title":"Lateral lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis for prevalence, risk factors, and location","volume":"50","author":"So","year":"2018","journal-title":"Int J Surg Lond Engl"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.640565","article-title":"Risk factors for central and lateral lymph node metastases in patients with papillary thyroid micro-carcinoma: retrospective analysis on 484 cases","volume":"12","author":"Huang","year":"2021","journal-title":"Front Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12957-021-02247-w","article-title":"Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study","volume":"19","author":"Li","year":"2021","journal-title":"World J Surg Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1186\/s12885-019-5835-6","article-title":"Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients","volume":"19","author":"Liu","year":"2019","journal-title":"BMC Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.937049","article-title":"Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis","volume":"13","author":"Chang","year":"2022","journal-title":"Front Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-06906-6","article-title":"Papillary thyroid carcinoma: an ultrasound-based nomogram improves the prediction of lymph node metastases in the central compartment","volume":"30","author":"Tian","year":"2020","journal-title":"Eur Radiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.789310","article-title":"Predictors and a prediction model for central cervical lymph node metastasis in papillary thyroid carcinoma (cN0)","volume":"12","author":"Gao","year":"2022","journal-title":"Front Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2017.0051","article-title":"2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma","volume":"14","author":"Gao","year":"2017","journal-title":"Cancer Biol Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/thy.2013.0367","article-title":"Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation","volume":"24","author":"Ito","year":"2014","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-009-0359-x","article-title":"Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes","volume":"34","author":"Sugitani","year":"2010","journal-title":"World J Surg"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0313","article-title":"Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery","volume":"26","author":"Oda","year":"2016","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.856278","article-title":"A clinical predictive model of central lymph node metastases in papillary thyroid carcinoma","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1776293\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:24:25Z","timestamp":1777523065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1776293\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":21,"alternative-id":["10.3389\/fendo.2026.1776293"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1776293","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"article-number":"1776293"}}